Medicine
Haloperidol decanoate 250 mg/5 mL injection
Haloperidol decanoate 250 mg/5 mL injection is a generic prescription medicine for intramuscular use, made by 5 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Do not refrigerate or freeze. Store at 20°C to 25°C (68°F to 77°F). Protect…
Key facts
- Active ingredient (INN)
- Haloperidol decanoate
- Brand
- Sold under the generic name
- Strength
- 250 mg/5 mL
- Dosage form
- Injection
- Route
- Intramuscular
- Packs
- 1 vial of 5 mL, 5 vials of 5 mL, 10 vials of 5 mL and 7 more
- Manufacturers
- Zydus LifesciencesIndiaLifestar PharmaIndiaGland PharmaIndiaSomerset TherapeuticsFresenius Kabi
- Origin register
- US FDA, United States
- Storage
- Do not refrigerate or freeze. Store at 20°C to 25°C (68°F to 77°F). Protect from light.
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 16 February 2000
- Identifiers
- RxCUI 859867, 859871, 1719803 +1DailyMed set ID 6d2d7612-ad47-4ee7-a42c-945c976d947b, 8a96195e-97cd-4161-96e0-494a1636fa9c, 1a0e38cb-fd9f-4962-9f81-5c0023ca6b4c +3NDC 70710-1462, 70756-624, 68083-137 +3Application ANDA211180, ANDA216730, ANDA205241 +2
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
Packs from every labeler of this generic presentation.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 1 vial, multi-dose in 1 carton / 5 mL in 1 vial, multi-dose | 70710-1462-1 | Zydus LifesciencesIndia | 14 November 2019 |
| 5 vial, multi-dose in 1 carton / 5 mL in 1 vial, multi-dose | 70710-1462-5 | Zydus LifesciencesIndia | 14 November 2019 |
| 1 vial, multi-dose in 1 carton / 5 mL in 1 vial, multi-dose | 70771-1852-1 | Zydus LifesciencesIndia | 14 November 2019 |
| 5 vial, multi-dose in 1 carton / 5 mL in 1 vial, multi-dose | 70771-1852-5 | Zydus LifesciencesIndia | 14 November 2019 |
| 1 vial in 1 carton / 5 mL in 1 vial | 68083-137-02 | Gland PharmaIndia | 16 January 2017 |
| 10 vial in 1 carton / 5 mL in 1 vial | 70756-624-10 | Lifestar PharmaIndia | 23 May 2023 |
| 1 vial in 1 carton / 5 mL in 1 vial | 70756-624-85 | Lifestar PharmaIndia | 23 May 2023 |
| 1 vial, multi-dose in 1 carton / 5 mL in 1 vial, multi-dose | 63323-469-05 | Fresenius Kabi | 16 February 2000 |
| 1 vial, multi-dose in 1 carton / 5 mL in 1 vial, multi-dose | 70069-382-01 | Somerset Therapeutics | 13 April 2019 |
| 5 vial, multi-dose in 1 carton / 5 mL in 1 vial, multi-dose | 70069-382-05 | Somerset Therapeutics | 4 April 2020 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 14 January 1986 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Haloperidol decanoate
Clinical summary
Haloperidol decanoate is a typical antipsychotic indicated for the treatment of patients with schizophrenia who require prolonged parenteral antipsychotic therapy. It is available as injection for intramuscular use. MedsAcross supplies Haloperidol decanoate for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about Haloperidol decanoateFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Haloperidol Decanoate prescribing information (Patriot Pharmaceuticals) · U.S. National Library of Medicine, DailyMed
Need Haloperidol decanoate 250 mg/5 mL injection for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.